San Diego, CA, United States of America

Brad M Savall

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 6.2

ph-index = 8

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):

Title: Brad M Savall: Innovator in Pharmaceutical Patents

Introduction: Brad M Savall is a prominent inventor based in San Diego, CA, known for his significant contributions to the pharmaceutical field. With a remarkable portfolio of 30 patents, Savall has focused on developing innovative compounds aimed at treating various medical conditions.

Latest Patents: Among his latest inventions are the compounds related to P2X7 modulators. These inventions include pharmaceutical compositions comprising these compounds and methodologies for their production and use. Additionally, he has developed disubstituted octahydropyrrolo[3,4-c]pyrrole compounds, which serve as orexin receptor modulators. These compounds are particularly noteworthy as they hold potential in treating conditions such as insomnia by targeting orexin activity.

Career Highlights: Brad has had a distinguished career within prestigious organizations like Janssen Pharmaceutica. His work in this leading pharmaceutical company has enabled him to advance his research and invention capabilities, making substantial impacts on the healthcare industry.

Collaborations: Throughout his career, Savall has collaborated with talented individuals such as Michael Anthony Letavic and Devin M Swanson, who have contributed to the successful development of his patents. These collaborations have further propelled his innovative research.

Conclusion: Brad M Savall's dedication to innovation in the pharmaceutical sector is evident through his extensive patent portfolio and collaborations. His contributions have the potential to revolutionize treatments and improve the quality of life for many individuals suffering from various disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…